Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zbtb33
|
ENSMUSG00000048047.3 | zinc finger and BTB domain containing 33 |
Chd2
|
ENSMUSG00000078671.4 | chromodomain helicase DNA binding protein 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_73541404_73541565 | Chd2 | 41 | 0.954337 | 0.71 | 1.1e-09 | Click! |
chr7_73541660_73541846 | Chd2 | 7 | 0.957441 | 0.66 | 4.7e-08 | Click! |
chr7_73537349_73537577 | Chd2 | 158 | 0.810811 | 0.57 | 4.5e-06 | Click! |
chr7_73478563_73478714 | Chd2 | 190 | 0.912568 | 0.43 | 9.0e-04 | Click! |
chr7_73441919_73442070 | Chd2 | 2257 | 0.202429 | 0.36 | 7.6e-03 | Click! |
chrX_38189372_38190414 | Zbtb33 | 59 | 0.963081 | 0.43 | 1.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_98202532_98203082 | 22.43 |
Cdk12 |
cyclin-dependent kinase 12 |
252 |
0.86 |
chr17_28690806_28691746 | 20.22 |
Mapk14 |
mitogen-activated protein kinase 14 |
53 |
0.94 |
chr3_152396566_152396793 | 19.52 |
Zzz3 |
zinc finger, ZZ domain containing 3 |
5 |
0.96 |
chr11_69395650_69395911 | 19.00 |
Naa38 |
N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
34 |
0.63 |
chrX_169996827_169997318 | 18.31 |
Gm15247 |
predicted gene 15247 |
10133 |
0.15 |
chrY_90771156_90771656 | 17.39 |
Gm47283 |
predicted gene, 47283 |
13332 |
0.16 |
chr7_133637466_133638239 | 15.97 |
Edrf1 |
erythroid differentiation regulatory factor 1 |
9 |
0.96 |
chr8_119558724_119558966 | 15.84 |
Mbtps1 |
membrane-bound transcription factor peptidase, site 1 |
110 |
0.94 |
chr9_54863248_54863811 | 14.09 |
Ireb2 |
iron responsive element binding protein 2 |
260 |
0.91 |
chrX_166440613_166441104 | 13.75 |
Trappc2 |
trafficking protein particle complex 2 |
82 |
0.6 |
chr11_115708497_115708923 | 13.27 |
Grb2 |
growth factor receptor bound protein 2 |
113 |
0.93 |
chr14_32159726_32160048 | 13.21 |
Ncoa4 |
nuclear receptor coactivator 4 |
22 |
0.96 |
chr1_165460347_165460798 | 12.76 |
Mpc2 |
mitochondrial pyruvate carrier 2 |
65 |
0.53 |
chr6_83325914_83326097 | 11.95 |
Mob1a |
MOB kinase activator 1A |
11 |
0.57 |
chr2_44926591_44927289 | 11.87 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
209 |
0.96 |
chr11_77607040_77608322 | 11.82 |
Taok1 |
TAO kinase 1 |
134 |
0.94 |
chr12_30584368_30584551 | 11.58 |
Tmem18 |
transmembrane protein 18 |
33 |
0.98 |
chr12_12428967_12429271 | 11.33 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
36504 |
0.21 |
chr13_111489569_111490138 | 10.73 |
Gpbp1 |
GC-rich promoter binding protein 1 |
175 |
0.95 |
chr7_113368807_113369977 | 10.66 |
Btbd10 |
BTB (POZ) domain containing 10 |
0 |
0.97 |
chr4_155812638_155813055 | 10.63 |
Ccnl2 |
cyclin L2 |
68 |
0.92 |
chr9_66350251_66351058 | 10.57 |
Herc1 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 |
128 |
0.96 |
chr14_20452172_20452333 | 10.53 |
Cfap70 |
cilia and flagella associated protein 70 |
26 |
0.96 |
chr5_140321254_140321818 | 10.47 |
Mad1l1 |
MAD1 mitotic arrest deficient 1-like 1 |
14 |
0.61 |
chr12_111537480_111538246 | 10.40 |
Eif5 |
eukaryotic translation initiation factor 5 |
153 |
0.92 |
chr3_113630048_113630235 | 10.31 |
Rnpc3 |
RNA-binding region (RNP1, RRM) containing 3 |
8 |
0.97 |
chr10_119239692_119240316 | 10.31 |
Cand1 |
cullin associated and neddylation disassociated 1 |
51 |
0.98 |
chr8_25840695_25841636 | 10.29 |
Ash2l |
ASH2 like histone lysine methyltransferase complex subunit |
378 |
0.8 |
chr11_90637995_90638823 | 10.23 |
Cox11 |
cytochrome c oxidase assembly protein 11, copper chaperone |
236 |
0.6 |
chr11_72689672_72690073 | 10.13 |
Ankfy1 |
ankyrin repeat and FYVE domain containing 1 |
134 |
0.96 |
chr6_72361930_72362320 | 10.12 |
Rnf181 |
ring finger protein 181 |
2 |
0.95 |
chr1_130716050_130716668 | 9.87 |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
545 |
0.35 |
chr10_81105810_81105996 | 9.70 |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
12 |
0.91 |
chr9_121718715_121719327 | 9.66 |
Nktr |
natural killer tumor recognition sequence |
148 |
0.92 |
chr3_135438241_135438464 | 9.51 |
Ube2d3 |
ubiquitin-conjugating enzyme E2D 3 |
36 |
0.8 |
chr11_85352595_85352790 | 9.36 |
Bcas3 |
breast carcinoma amplified sequence 3 |
475 |
0.84 |
chr6_34780285_34780491 | 9.31 |
Agbl3 |
ATP/GTP binding protein-like 3 |
44 |
0.96 |
chr11_84870292_84871034 | 9.07 |
Ggnbp2 |
gametogenetin binding protein 2 |
17 |
0.96 |
chr15_102625375_102625990 | 9.05 |
Atf7 |
activating transcription factor 7 |
218 |
0.75 |
chr1_128417211_128417648 | 8.95 |
Dars |
aspartyl-tRNA synthetase |
61 |
0.97 |
chr2_131179970_131180268 | 8.93 |
Cenpb |
centromere protein B |
52 |
0.95 |
chr12_113000321_113000559 | 8.91 |
Brf1 |
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit |
8 |
0.88 |
chr4_120825669_120825856 | 8.90 |
Nfyc |
nuclear transcription factor-Y gamma |
55 |
0.96 |
chr11_22973029_22973183 | 8.90 |
Zrsr1 |
zinc finger (CCCH type), RNA binding motif and serine/arginine rich 1 |
109 |
0.68 |
chr1_155973278_155973761 | 8.86 |
Gm9694 |
predicted gene 9694 |
201 |
0.57 |
chr6_11727480_11727656 | 8.85 |
Ndufa4 |
Ndufa4, mitochondrial complex associated |
179825 |
0.03 |
chr2_37422962_37423560 | 8.76 |
Rc3h2 |
ring finger and CCCH-type zinc finger domains 2 |
358 |
0.8 |
chr4_120924508_120925215 | 8.76 |
Exo5 |
exonuclease 5 |
144 |
0.93 |
chr13_58402391_58403113 | 8.70 |
Rmi1 |
RecQ mediated genome instability 1 |
52 |
0.56 |
chr15_76080882_76081077 | 8.66 |
Puf60 |
poly-U binding splicing factor 60 |
55 |
0.93 |
chr15_81871863_81872058 | 8.43 |
Phf5a |
PHD finger protein 5A |
49 |
0.81 |
chr3_105959149_105959347 | 8.41 |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
2 |
0.52 |
chr2_168207267_168207697 | 8.38 |
Adnp |
activity-dependent neuroprotective protein |
370 |
0.77 |
chr1_119837439_119838190 | 8.32 |
Ptpn4 |
protein tyrosine phosphatase, non-receptor type 4 |
201 |
0.91 |
chr19_53390490_53390959 | 8.20 |
8030456M14Rik |
RIKEN cDNA 8030456M14 gene |
65 |
0.61 |
chr11_105181488_105182080 | 8.19 |
Tlk2 |
tousled-like kinase 2 (Arabidopsis) |
9 |
0.84 |
chr3_157947094_157947288 | 8.06 |
Ankrd13c |
ankyrin repeat domain 13c |
48 |
0.96 |
chr11_34833484_34833793 | 8.06 |
Spdl1 |
spindle apparatus coiled-coil protein 1 |
3 |
0.98 |
chr6_148211952_148212369 | 8.05 |
Ergic2 |
ERGIC and golgi 2 |
53 |
0.54 |
chr11_115603397_115603986 | 8.01 |
Gga3 |
golgi associated, gamma adaptin ear containing, ARF binding protein 3 |
33 |
0.73 |
chr14_105177260_105177487 | 7.86 |
Rbm26 |
RNA binding motif protein 26 |
46 |
0.97 |
chr5_123906785_123907594 | 7.82 |
Denr |
density-regulated protein |
14 |
0.96 |
chr1_190107153_190107349 | 7.79 |
Gm28172 |
predicted gene 28172 |
61419 |
0.11 |
chr19_14597310_14597766 | 7.77 |
Tle4 |
transducin-like enhancer of split 4 |
513 |
0.86 |
chr1_130716733_130717629 | 7.76 |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
57 |
0.6 |
chr6_146724896_146725088 | 7.66 |
Stk38l |
serine/threonine kinase 38 like |
3 |
0.97 |
chrX_85573362_85573988 | 7.62 |
Tab3 |
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
347 |
0.9 |
chr1_179803571_179803755 | 7.59 |
Ahctf1 |
AT hook containing transcription factor 1 |
17 |
0.81 |
chr17_29268729_29269079 | 7.57 |
BC004004 |
cDNA sequence BC004004 |
12 |
0.95 |
chr3_88335932_88336369 | 7.54 |
Tmem79 |
transmembrane protein 79 |
2 |
0.58 |
chr7_55793957_55794271 | 7.45 |
Tubgcp5 |
tubulin, gamma complex associated protein 5 |
40 |
0.98 |
chr15_31601657_31601987 | 7.32 |
Cct5 |
chaperonin containing Tcp1, subunit 5 (epsilon) |
18 |
0.5 |
chr5_122264359_122264533 | 7.32 |
Tctn1 |
tectonic family member 1 |
14 |
0.96 |
chr9_109094576_109096217 | 7.24 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr15_83149261_83149455 | 7.21 |
Poldip3 |
polymerase (DNA-directed), delta interacting protein 3 |
22 |
0.79 |
chr9_64281357_64281699 | 7.13 |
Tipin |
timeless interacting protein |
53 |
0.96 |
chr17_39846240_39846403 | 7.12 |
CT010467.1 |
18s RNA, related sequence 5 |
32 |
0.97 |
chr1_58392990_58393224 | 7.08 |
Bzw1 |
basic leucine zipper and W2 domains 1 |
17 |
0.97 |
chr17_74489230_74489593 | 7.07 |
Yipf4 |
Yip1 domain family, member 4 |
82 |
0.96 |
chr10_69908447_69908713 | 7.05 |
Ank3 |
ankyrin 3, epithelial |
6285 |
0.32 |
chr12_84285172_84285857 | 7.02 |
Ptgr2 |
prostaglandin reductase 2 |
101 |
0.95 |
chr15_6708302_6709258 | 6.98 |
Rictor |
RPTOR independent companion of MTOR, complex 2 |
397 |
0.87 |
chr3_122984568_122984748 | 6.94 |
Usp53 |
ubiquitin specific peptidase 53 |
148 |
0.93 |
chr2_119477837_119478389 | 6.78 |
Ino80 |
INO80 complex subunit |
426 |
0.81 |
chr11_119299981_119300542 | 6.73 |
Eif4a3 |
eukaryotic translation initiation factor 4A3 |
172 |
0.92 |
chr14_57826138_57826325 | 6.68 |
Mrpl57 |
mitochondrial ribosomal protein L57 |
3 |
0.51 |
chr4_86575303_86575784 | 6.64 |
Rraga |
Ras-related GTP binding A |
125 |
0.94 |
chr12_82168898_82169558 | 6.61 |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
92 |
0.54 |
chr4_119077561_119077722 | 6.57 |
Gm12866 |
predicted gene 12866 |
8530 |
0.11 |
chr8_117801453_117801821 | 6.54 |
Mphosph6 |
M phase phosphoprotein 6 |
290 |
0.62 |
chr5_99632537_99632938 | 6.52 |
4930405H06Rik |
RIKEN cDNA 4930405H06 gene |
6901 |
0.16 |
chr18_35561956_35562337 | 6.50 |
Matr3 |
matrin 3 |
0 |
0.94 |
chr2_60209324_60210635 | 6.43 |
Marchf7 |
membrane associated ring-CH-type finger 7 |
66 |
0.6 |
chr11_32267589_32267769 | 6.41 |
Nprl3 |
nitrogen permease regulator-like 3 |
10 |
0.96 |
chr17_33628969_33629252 | 6.41 |
Zfp414 |
zinc finger protein 414 |
9 |
0.95 |
chr8_40307842_40308020 | 6.38 |
Mir7666 |
microRNA 7666 |
2 |
0.81 |
chr10_80039686_80039982 | 6.36 |
Polr2e |
polymerase (RNA) II (DNA directed) polypeptide E |
39 |
0.94 |
chr17_45433453_45433908 | 6.36 |
Cdc5l |
cell division cycle 5-like (S. pombe) |
57 |
0.52 |
chr15_99724323_99725930 | 6.34 |
Cox14 |
cytochrome c oxidase assembly protein 14 |
521 |
0.41 |
chr1_152902778_152903485 | 6.13 |
Smg7 |
Smg-7 homolog, nonsense mediated mRNA decay factor (C. elegans) |
485 |
0.76 |
chr3_107333549_107333738 | 6.09 |
Rbm15 |
RNA binding motif protein 15 |
30 |
0.97 |
chrX_164269205_164269889 | 6.08 |
Pir |
pirin |
0 |
0.96 |
chr11_68901306_68901892 | 6.02 |
Rpl26 |
ribosomal protein L26 |
11 |
0.95 |
chr19_40831125_40831318 | 6.00 |
Ccnj |
cyclin J |
58 |
0.97 |
chr2_91634834_91635130 | 5.97 |
F2 |
coagulation factor II |
1413 |
0.27 |
chr4_43629534_43629723 | 5.97 |
Gm25262 |
predicted gene, 25262 |
1797 |
0.14 |
chr3_152210213_152210595 | 5.97 |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
18 |
0.58 |
chr5_96162084_96163134 | 5.95 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
619 |
0.75 |
chrX_13072728_13072993 | 5.93 |
Usp9x |
ubiquitin specific peptidase 9, X chromosome |
1346 |
0.44 |
chr3_105686913_105687657 | 5.93 |
Ddx20 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 |
159 |
0.93 |
chr14_20793233_20794132 | 5.92 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
284 |
0.68 |
chr17_39845065_39845666 | 5.92 |
CT010467.1 |
18s RNA, related sequence 5 |
988 |
0.52 |
chr10_115384709_115385039 | 5.90 |
Zfc3h1 |
zinc finger, C3H1-type containing |
85 |
0.84 |
chr19_12795524_12796032 | 5.87 |
Zfp91 |
zinc finger protein 91 |
348 |
0.51 |
chr9_58581580_58582365 | 5.86 |
Nptn |
neuroplastin |
268 |
0.91 |
chr7_127511737_127512058 | 5.82 |
Srcap |
Snf2-related CREBBP activator protein |
86 |
0.88 |
chr5_88720312_88721016 | 5.80 |
Mob1b |
MOB kinase activator 1B |
191 |
0.93 |
chr8_11444309_11444526 | 5.76 |
Col4a2 |
collagen, type IV, alpha 2 |
3308 |
0.16 |
chr19_44106988_44107591 | 5.76 |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
7 |
0.96 |
chrX_13071715_13072117 | 5.75 |
Usp9x |
ubiquitin specific peptidase 9, X chromosome |
402 |
0.85 |
chr5_139252089_139252540 | 5.75 |
Get4 |
golgi to ER traffic protein 4 |
10 |
0.97 |
chr11_59839724_59839926 | 5.75 |
Cops3 |
COP9 signalosome subunit 3 |
13 |
0.85 |
chr5_34659992_34660366 | 5.70 |
Nop14 |
NOP14 nucleolar protein |
31 |
0.71 |
chr7_126260373_126260529 | 5.69 |
Sbk1 |
SH3-binding kinase 1 |
11589 |
0.11 |
chr12_105026209_105026535 | 5.64 |
Gm47650 |
predicted gene, 47650 |
1591 |
0.21 |
chr9_25252365_25252756 | 5.64 |
Septin7 |
septin 7 |
16 |
0.98 |
chr19_8947047_8947218 | 5.62 |
Mta2 |
metastasis-associated gene family, member 2 |
732 |
0.37 |
chr14_60250921_60251643 | 5.61 |
Gm49336 |
predicted gene, 49336 |
124 |
0.53 |
chr17_39843553_39843722 | 5.61 |
CT010467.1 |
18s RNA, related sequence 5 |
2716 |
0.25 |
chr11_3408789_3409445 | 5.60 |
Limk2 |
LIM motif-containing protein kinase 2 |
57 |
0.96 |
chr15_79694652_79694831 | 5.59 |
Gtpbp1 |
GTP binding protein 1 |
561 |
0.53 |
chr13_3537924_3538096 | 5.57 |
Gdi2 |
guanosine diphosphate (GDP) dissociation inhibitor 2 |
53 |
0.97 |
chr6_30509597_30509899 | 5.54 |
Tmem209 |
transmembrane protein 209 |
1 |
0.58 |
chr1_167308575_167308778 | 5.53 |
Tmco1 |
transmembrane and coiled-coil domains 1 |
6 |
0.96 |
chr13_59585030_59585385 | 5.51 |
Agtpbp1 |
ATP/GTP binding protein 1 |
4 |
0.52 |
chr2_174329445_174331091 | 5.48 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr3_105959363_105959565 | 5.48 |
Gm42890 |
predicted gene 42890 |
39 |
0.41 |
chr3_33799993_33800607 | 5.45 |
Ttc14 |
tetratricopeptide repeat domain 14 |
37 |
0.97 |
chr12_80643316_80643974 | 5.40 |
Erh |
ERH mRNA splicing and mitosis factor |
155 |
0.59 |
chr5_31048525_31048707 | 5.40 |
Atraid |
all-trans retinoic acid induced differentiation factor |
19 |
0.51 |
chr2_3332926_3333325 | 5.38 |
Rpp38 |
ribonuclease P/MRP 38 subunit |
482 |
0.71 |
chr8_94837718_94838480 | 5.37 |
Ciapin1 |
cytokine induced apoptosis inhibitor 1 |
162 |
0.56 |
chr18_36286914_36287094 | 5.37 |
Pura |
purine rich element binding protein A |
5907 |
0.19 |
chr12_9029867_9030308 | 5.35 |
Ttc32 |
tetratricopeptide repeat domain 32 |
59 |
0.98 |
chr19_43675348_43675977 | 5.32 |
BC037704 |
cDNA sequence BC037704 |
484 |
0.55 |
chr13_54564841_54565501 | 5.30 |
4833439L19Rik |
RIKEN cDNA 4833439L19 gene |
120 |
0.93 |
chr3_86142517_86142868 | 5.28 |
Rps3a1 |
ribosomal protein S3A1 |
10 |
0.53 |
chr2_126875526_126876097 | 5.21 |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
306 |
0.88 |
chr14_27428418_27428882 | 5.20 |
Tasor |
transcription activation suppressor |
184 |
0.95 |
chr1_180936513_180937023 | 5.20 |
Lefty1 |
left right determination factor 1 |
103 |
0.93 |
chr2_73892016_73892788 | 5.20 |
Atf2 |
activating transcription factor 2 |
128 |
0.97 |
chr2_118256854_118257069 | 5.18 |
Fsip1 |
fibrous sheath-interacting protein 1 |
5 |
0.97 |
chr11_69070656_69070927 | 5.18 |
Tmem107 |
transmembrane protein 107 |
15 |
0.92 |
chrX_101288529_101288688 | 5.16 |
Med12 |
mediator complex subunit 12 |
2584 |
0.14 |
chr11_78183504_78183708 | 5.13 |
Rpl23a |
ribosomal protein L23A |
22 |
0.84 |
chr3_96635552_96636141 | 5.10 |
Pex11b |
peroxisomal biogenesis factor 11 beta |
13 |
0.82 |
chr8_70042658_70042830 | 5.09 |
Mau2 |
MAU2 sister chromatid cohesion factor |
10 |
0.53 |
chr6_125215083_125215673 | 5.09 |
Vamp1 |
vesicle-associated membrane protein 1 |
173 |
0.85 |
chr16_23107946_23108450 | 5.06 |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
281 |
0.63 |
chr5_53589169_53589884 | 5.05 |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
688 |
0.74 |
chr1_86358717_86359236 | 5.05 |
Ncl |
nucleolin |
7 |
0.89 |
chr5_53590614_53590795 | 5.02 |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
233 |
0.94 |
chr9_62122592_62123246 | 5.01 |
Glce |
glucuronyl C5-epimerase |
264 |
0.56 |
chr4_135855773_135856058 | 5.01 |
Srsf10 |
serine and arginine-rich splicing factor 10 |
37 |
0.95 |
chr1_185203642_185204638 | 4.96 |
Rab3gap2 |
RAB3 GTPase activating protein subunit 2 |
23 |
0.97 |
chr2_69897016_69897323 | 4.96 |
Ubr3 |
ubiquitin protein ligase E3 component n-recognin 3 |
77 |
0.96 |
chr9_57467552_57468361 | 4.93 |
Scamp5 |
secretory carrier membrane protein 5 |
39 |
0.95 |
chr18_9957690_9958213 | 4.91 |
Thoc1 |
THO complex 1 |
45 |
0.97 |
chr11_87759429_87759940 | 4.90 |
Tspoap1 |
TSPO associated protein 1 |
857 |
0.36 |
chr7_103909517_103909932 | 4.90 |
Olfr65 |
olfactory receptor 65 |
3382 |
0.08 |
chr11_78031652_78032386 | 4.88 |
Dhrs13 |
dehydrogenase/reductase (SDR family) member 13 |
261 |
0.7 |
chr5_34336055_34336725 | 4.86 |
Rnf4 |
ring finger protein 4 |
0 |
0.96 |
chr5_122353899_122354085 | 4.85 |
Rad9b |
RAD9 checkpoint clamp component B |
228 |
0.62 |
chr11_88863821_88864845 | 4.81 |
Akap1 |
A kinase (PRKA) anchor protein 1 |
253 |
0.9 |
chr8_60859605_60859923 | 4.79 |
Gm45485 |
predicted gene 45485 |
13452 |
0.16 |
chr18_75000413_75000592 | 4.78 |
Rpl17 |
ribosomal protein L17 |
25 |
0.86 |
chr2_157367729_157368134 | 4.77 |
Manbal |
mannosidase, beta A, lysosomal-like |
337 |
0.87 |
chr16_31275137_31275499 | 4.75 |
Ppp1r2 |
protein phosphatase 1, regulatory inhibitor subunit 2 |
41 |
0.96 |
chr6_146577671_146578047 | 4.75 |
Fgfr1op2 |
FGFR1 oncogene partner 2 |
0 |
0.5 |
chr11_120633520_120633920 | 4.72 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
120 |
0.87 |
chr4_43562753_43563203 | 4.70 |
Creb3 |
cAMP responsive element binding protein 3 |
31 |
0.77 |
chr5_90366116_90366444 | 4.70 |
Ankrd17 |
ankyrin repeat domain 17 |
52 |
0.83 |
chr3_69004482_69004676 | 4.65 |
Ift80 |
intraflagellar transport 80 |
9 |
0.66 |
chr17_15375662_15377138 | 4.63 |
Dll1 |
delta like canonical Notch ligand 1 |
424 |
0.8 |
chr5_134313726_134314672 | 4.63 |
Gtf2i |
general transcription factor II I |
179 |
0.92 |
chr4_53246185_53246519 | 4.57 |
4930522O17Rik |
RIKEN cDNA 4930522O17 gene |
156 |
0.95 |
chr5_121452589_121453180 | 4.54 |
Tmem116 |
transmembrane protein 116 |
175 |
0.7 |
chr17_25942773_25943121 | 4.53 |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
85 |
0.91 |
chr11_98192905_98193456 | 4.53 |
Med1 |
mediator complex subunit 1 |
80 |
0.95 |
chr19_44301374_44301539 | 4.53 |
Mir5114 |
microRNA 5114 |
1715 |
0.23 |
chr2_151038619_151039849 | 4.51 |
Nanp |
N-acetylneuraminic acid phosphatase |
128 |
0.52 |
chr12_69168710_69169116 | 4.48 |
Lrr1 |
leucine rich repeat protein 1 |
71 |
0.91 |
chr2_69861726_69862139 | 4.48 |
Ssb |
Sjogren syndrome antigen B |
246 |
0.87 |
chr10_127311160_127311405 | 4.47 |
Mars1 |
methionine-tRNA synthetase 1 |
396 |
0.63 |
chrX_10718808_10719253 | 4.46 |
Gm14493 |
predicted gene 14493 |
320 |
0.84 |
chr2_69885507_69885694 | 4.45 |
Mettl5 |
methyltransferase like 5 |
3 |
0.62 |
chr17_53566897_53568169 | 4.44 |
Kat2b |
K(lysine) acetyltransferase 2B |
562 |
0.71 |
chr13_63814987_63815914 | 4.44 |
Ercc6l2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 like 2 |
25 |
0.97 |
chrX_101419755_101420082 | 4.43 |
Zmym3 |
zinc finger, MYM-type 3 |
4 |
0.97 |
chr3_79567751_79567962 | 4.43 |
Fnip2 |
folliculin interacting protein 2 |
60 |
0.81 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 19.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
4.3 | 13.0 | GO:0032439 | endosome localization(GO:0032439) |
4.0 | 12.0 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
3.1 | 15.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
3.0 | 11.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
2.9 | 8.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
2.7 | 8.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.6 | 31.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
2.6 | 7.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.6 | 12.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
2.4 | 9.6 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
2.3 | 7.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
2.3 | 6.8 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
2.0 | 6.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
2.0 | 8.0 | GO:0048478 | replication fork protection(GO:0048478) |
1.9 | 5.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.9 | 5.6 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
1.8 | 5.4 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.8 | 5.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.8 | 5.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.8 | 5.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
1.7 | 17.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.7 | 5.1 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.7 | 10.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.7 | 8.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.6 | 4.9 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.6 | 8.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
1.6 | 6.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.6 | 4.7 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.6 | 4.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.6 | 4.7 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.5 | 6.2 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
1.5 | 6.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.5 | 10.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.5 | 13.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.4 | 4.3 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.4 | 4.2 | GO:0070268 | cornification(GO:0070268) |
1.4 | 4.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.4 | 2.8 | GO:0046070 | dGTP metabolic process(GO:0046070) |
1.4 | 9.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.3 | 4.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.3 | 3.9 | GO:0019042 | viral latency(GO:0019042) |
1.3 | 3.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.3 | 3.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.3 | 14.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
1.2 | 3.7 | GO:0015817 | histidine transport(GO:0015817) |
1.2 | 3.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.2 | 3.7 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.2 | 13.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
1.2 | 6.1 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.2 | 4.9 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.2 | 3.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.2 | 6.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.2 | 6.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
1.2 | 3.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.2 | 3.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.2 | 7.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.2 | 7.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.2 | 5.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.2 | 3.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.2 | 4.7 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.2 | 3.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.2 | 3.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.2 | 3.5 | GO:0051182 | coenzyme transport(GO:0051182) |
1.1 | 8.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.1 | 9.1 | GO:0010388 | cullin deneddylation(GO:0010388) |
1.1 | 1.1 | GO:0006848 | pyruvate transport(GO:0006848) |
1.1 | 2.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.1 | 3.2 | GO:0015888 | thiamine transport(GO:0015888) |
1.0 | 6.3 | GO:0042268 | regulation of cytolysis(GO:0042268) |
1.0 | 3.1 | GO:0048254 | snoRNA localization(GO:0048254) |
1.0 | 4.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.0 | 1.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
1.0 | 3.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.0 | 4.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.0 | 9.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
1.0 | 2.0 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
1.0 | 6.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
1.0 | 10.6 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
1.0 | 6.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 2.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 2.8 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.9 | 11.1 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.9 | 14.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.9 | 3.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.9 | 2.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.9 | 4.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.9 | 4.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.9 | 9.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.9 | 6.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.9 | 2.6 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.9 | 2.6 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.9 | 2.6 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.9 | 4.3 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.9 | 2.6 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 1.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.8 | 5.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.8 | 2.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.8 | 3.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.8 | 2.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.8 | 2.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.8 | 3.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.8 | 1.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.8 | 3.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.8 | 3.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.8 | 1.6 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.8 | 8.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.8 | 4.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.8 | 2.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.8 | 4.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.8 | 3.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.8 | 2.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.8 | 2.3 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.8 | 3.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.8 | 2.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.8 | 4.6 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.8 | 2.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 5.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.8 | 0.8 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.7 | 2.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.7 | 9.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.7 | 3.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.7 | 2.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.7 | 4.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 2.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.7 | 4.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.7 | 4.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.7 | 8.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.7 | 4.0 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.7 | 2.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.7 | 2.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.7 | 4.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 1.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.6 | 8.4 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.6 | 3.8 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.6 | 3.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.6 | 2.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.6 | 0.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.6 | 2.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.6 | 1.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.6 | 2.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.6 | 3.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.6 | 1.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.6 | 1.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.6 | 1.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.6 | 6.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.6 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 3.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.6 | 1.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 1.2 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.6 | 0.6 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.6 | 2.9 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 11.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.6 | 1.7 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.6 | 5.1 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.6 | 2.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.6 | 6.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.6 | 0.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 6.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.6 | 1.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.6 | 0.6 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.6 | 1.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 1.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 1.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.5 | 2.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.5 | 2.7 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.5 | 2.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 4.9 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.5 | 1.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 3.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 2.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.5 | 1.6 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.5 | 2.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 14.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.5 | 2.6 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.5 | 24.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.5 | 1.5 | GO:0036257 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.5 | 5.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.5 | 1.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.5 | 3.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.5 | 2.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 9.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.5 | 2.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.5 | 1.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.5 | 4.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.5 | 4.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.5 | 1.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.5 | 2.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 7.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 3.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.5 | 3.4 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.5 | 2.4 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 4.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.5 | 2.9 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.5 | 1.0 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.5 | 2.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 5.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.5 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.5 | 1.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 6.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 2.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.5 | 1.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 1.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 1.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.5 | 1.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 1.9 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.5 | 1.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 3.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.5 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 1.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 1.8 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.5 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.5 | 1.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 1.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.5 | 1.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 1.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 2.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 0.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.4 | 7.3 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.4 | 0.9 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.4 | 3.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.4 | 0.9 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.4 | 1.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.4 | 3.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 1.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 1.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 1.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.4 | 4.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.4 | 8.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.4 | 3.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 2.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 1.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 1.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.4 | 7.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 12.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 1.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 4.4 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.4 | 1.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.4 | 1.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 2.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.4 | 0.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 1.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 1.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 17.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 1.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.4 | 0.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.4 | 2.3 | GO:1900364 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.4 | 4.6 | GO:0043486 | histone exchange(GO:0043486) |
0.4 | 1.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.4 | 3.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 0.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 2.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 0.4 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.4 | 3.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.4 | 4.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.4 | 0.7 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 2.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 0.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 2.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.4 | 8.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 1.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.4 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.4 | 1.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 15.1 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 6.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 0.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 3.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 1.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 4.1 | GO:0051904 | pigment granule transport(GO:0051904) |
0.3 | 0.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 2.0 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.3 | 2.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 1.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 3.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.3 | 0.3 | GO:1904833 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.3 | 1.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 4.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 1.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 2.3 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 5.0 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.3 | 1.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 3.6 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 1.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 0.7 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.3 | 1.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 2.6 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.3 | 7.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 10.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 1.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.3 | 0.3 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.3 | 5.5 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.3 | 1.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 3.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.3 | 0.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.3 | 0.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 1.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 1.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 0.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 2.4 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 0.3 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.3 | 0.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 0.6 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.3 | 11.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 7.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.3 | 0.9 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.3 | 0.6 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 1.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 2.6 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 1.7 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 0.6 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 1.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 2.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 0.6 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 3.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 0.8 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.3 | 0.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 1.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 0.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 2.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 1.1 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.3 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 1.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.3 | 2.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 0.5 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.3 | 1.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 1.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 0.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 0.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 0.8 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 2.6 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 1.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.3 | 3.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 1.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 4.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.3 | 0.5 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.3 | 0.8 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.3 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 1.3 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
0.3 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 0.3 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.3 | 0.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.3 | 0.8 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.3 | 1.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.3 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.3 | 3.0 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.2 | 0.5 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 1.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 5.5 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.2 | 1.5 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 1.7 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 2.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 3.7 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 3.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.2 | 1.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 1.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.5 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.2 | 1.0 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 1.0 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 7.1 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 0.9 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 0.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.2 | 4.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.7 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 0.7 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 3.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 1.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 2.8 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 0.5 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.7 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 1.6 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.2 | 5.9 | GO:0003170 | heart valve development(GO:0003170) |
0.2 | 1.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.2 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 0.2 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.2 | 1.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 1.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.2 | 0.7 | GO:0033048 | negative regulation of mitotic sister chromatid segregation(GO:0033048) |
0.2 | 0.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 1.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 0.9 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 3.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.2 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
0.2 | 1.9 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.9 | GO:0043038 | amino acid activation(GO:0043038) |
0.2 | 1.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 4.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.2 | 2.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 1.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.8 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 3.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 0.4 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 1.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.2 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 2.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 1.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 2.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 1.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 2.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 5.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.6 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.2 | 1.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.4 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.2 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 1.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 6.9 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.2 | 0.2 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 1.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 1.0 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.2 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 3.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 0.9 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.2 | 0.8 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.9 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.2 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 1.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 3.9 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.2 | 0.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 3.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.9 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.2 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 2.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 1.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 1.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 9.4 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.5 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.2 | 0.7 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 2.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 0.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 0.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 26.0 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.2 | 1.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 3.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 1.3 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.2 | 1.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 1.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 0.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 1.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.5 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.2 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.6 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 0.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 3.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 2.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 1.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 1.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.9 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 1.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 3.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 4.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.1 | 1.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 1.8 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 1.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.6 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.1 | 0.4 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 3.6 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 0.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 3.3 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 5.6 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 5.3 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.1 | GO:0003166 | bundle of His development(GO:0003166) |
0.1 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.6 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 1.2 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 2.8 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.8 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.4 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.9 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.4 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 2.4 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 1.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.1 | 0.6 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.1 | 1.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.8 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.3 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.3 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.7 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 1.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 1.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.7 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 2.0 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.3 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.6 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.5 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.7 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 1.1 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 3.1 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 1.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 2.3 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 2.6 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 1.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 0.8 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.6 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 1.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 2.2 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 2.3 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.3 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.1 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 0.4 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:2000483 | detection of bacterial lipoprotein(GO:0042494) negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 2.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 1.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 1.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.5 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.1 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.3 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.3 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 2.6 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 2.5 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 1.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.1 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.1 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 1.1 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 3.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 4.5 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.2 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 1.8 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 0.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.6 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.1 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.2 | GO:0051197 | positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0019740 | nitrogen utilization(GO:0019740) ammonium transmembrane transport(GO:0072488) |
0.1 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.7 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.4 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.6 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.2 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 6.2 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.6 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 4.1 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.1 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 1.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.7 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 0.5 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.0 | GO:0043307 | eosinophil activation(GO:0043307) |
0.0 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.0 | 0.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.2 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.3 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.1 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.0 | 0.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.0 | 0.0 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.0 | 0.2 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.0 | 0.0 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 1.2 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.0 | 0.0 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.8 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.0 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.0 | 0.0 | GO:0060066 | oviduct development(GO:0060066) |
0.0 | 0.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.0 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.0 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.4 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 1.1 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.0 | 0.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.3 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.3 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.5 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.2 | GO:0045953 | negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.8 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.1 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.4 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.1 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.0 | GO:0050904 | diapedesis(GO:0050904) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.0 | 0.0 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.0 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.3 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.0 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.0 | 0.1 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.0 | 0.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:0002894 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.0 | 0.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.0 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.3 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.1 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.0 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.0 | GO:0002885 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) regulation of hypersensitivity(GO:0002883) positive regulation of hypersensitivity(GO:0002885) |
0.0 | 0.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.2 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.0 | 0.1 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.0 | 0.0 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.0 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.0 | GO:0045924 | regulation of female receptivity(GO:0045924) positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.5 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.0 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.0 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.0 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.0 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.0 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.9 | GO:0098792 | xenophagy(GO:0098792) |
0.0 | 0.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.1 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.0 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.0 | 0.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.0 | 0.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.0 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.0 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.0 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.0 | 0.1 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.0 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.0 | 0.0 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.0 | 0.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.0 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.1 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.0 | 0.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.0 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.0 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.2 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.0 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.5 | GO:0031417 | NatC complex(GO:0031417) |
3.1 | 12.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
3.1 | 12.2 | GO:1990130 | Iml1 complex(GO:1990130) |
3.0 | 12.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.2 | 10.8 | GO:0089701 | U2AF(GO:0089701) |
2.1 | 6.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
2.0 | 15.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.9 | 30.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
1.9 | 5.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.7 | 22.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.7 | 6.8 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.4 | 5.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.4 | 2.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.3 | 5.4 | GO:0030689 | Noc complex(GO:0030689) |
1.2 | 8.5 | GO:0030008 | TRAPP complex(GO:0030008) |
1.2 | 8.3 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
1.1 | 3.4 | GO:1990423 | RZZ complex(GO:1990423) |
1.1 | 14.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.1 | 8.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.0 | 11.2 | GO:0000346 | transcription export complex(GO:0000346) |
1.0 | 10.0 | GO:0031932 | TORC2 complex(GO:0031932) |
1.0 | 4.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.0 | 19.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
1.0 | 1.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.9 | 2.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.9 | 2.7 | GO:0032010 | phagolysosome(GO:0032010) |
0.9 | 2.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.9 | 3.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.9 | 5.2 | GO:0000796 | condensin complex(GO:0000796) |
0.9 | 7.9 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.9 | 7.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.9 | 4.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.9 | 7.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.9 | 2.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.9 | 8.6 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 13.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.8 | 4.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.8 | 7.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.8 | 6.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.8 | 14.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.7 | 23.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 3.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 2.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.7 | 2.9 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.7 | 14.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.7 | 3.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.7 | 9.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.7 | 2.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 1.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 2.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 3.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.6 | 1.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.6 | 5.5 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.6 | 3.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.6 | 1.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.6 | 3.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.6 | 7.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.6 | 2.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 15.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.6 | 4.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 1.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 2.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.5 | 3.8 | GO:0090544 | BAF-type complex(GO:0090544) |
0.5 | 3.2 | GO:0051286 | cell tip(GO:0051286) |
0.5 | 13.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.5 | 5.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 7.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.5 | 2.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.5 | 1.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.5 | 1.5 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 1.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 4.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 1.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 5.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.5 | 2.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 1.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 9.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 1.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 1.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 3.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 4.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 1.8 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 1.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 11.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 1.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.4 | 2.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 3.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 0.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 1.3 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 6.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 2.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 1.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 1.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 2.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 2.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.4 | 28.7 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 2.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 1.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 2.8 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 2.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.3 | 5.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.3 | 2.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 9.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 2.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 4.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 6.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 5.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 4.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 14.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 12.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 1.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 3.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 2.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 3.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 12.0 | GO:0005844 | polysome(GO:0005844) |
0.3 | 2.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 10.6 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 2.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 5.1 | GO:0044452 | nucleolar part(GO:0044452) |
0.3 | 1.2 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 8.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 6.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 4.3 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 2.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 0.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 1.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 3.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.3 | 3.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 1.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 0.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 0.8 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 1.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 5.1 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 1.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 0.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 1.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 1.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 2.8 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 2.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 9.0 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.2 | 5.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 2.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 0.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 6.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 4.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 9.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 1.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 3.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 1.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 4.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 4.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 2.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 2.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 3.5 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 1.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.7 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 11.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 1.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 2.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 8.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 3.1 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 2.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.2 | 14.8 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 1.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 11.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 1.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 2.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 5.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 8.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 4.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 2.3 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 2.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 9.1 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 12.1 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 2.3 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.5 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 1.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 1.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.0 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 1.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 9.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 3.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 8.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 8.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 12.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 10.6 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 3.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 0.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 6.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 4.0 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 2.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 1.5 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 31.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.6 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 1.4 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.4 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 120.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 91.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 0.6 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 1.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 1.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.1 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 5.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 2.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 2.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 9.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 7.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.1 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.3 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 0.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 1.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.0 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 1.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 1.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 1.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 6.9 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 3.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.5 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 1.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 2.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0030135 | coated vesicle(GO:0030135) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 1.0 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 3.5 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 3.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 4.9 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 1.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 3.3 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 1.1 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.0 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.0 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.0 | GO:1990696 | USH2 complex(GO:1990696) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
3.8 | 19.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
3.7 | 11.1 | GO:1990188 | euchromatin binding(GO:1990188) |
2.6 | 10.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.3 | 11.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
2.3 | 7.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.1 | 8.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
2.0 | 12.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.0 | 7.9 | GO:0043515 | kinetochore binding(GO:0043515) |
1.9 | 5.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.9 | 7.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.8 | 5.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.7 | 1.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
1.7 | 6.7 | GO:0036033 | mediator complex binding(GO:0036033) |
1.6 | 3.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.6 | 4.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.6 | 4.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.5 | 7.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.5 | 7.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.4 | 8.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.4 | 22.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.3 | 26.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.3 | 5.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.3 | 3.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.3 | 5.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.3 | 10.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.3 | 3.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.3 | 3.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.3 | 3.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.3 | 10.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.3 | 5.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.2 | 4.9 | GO:0038100 | nodal binding(GO:0038100) |
1.2 | 3.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.2 | 1.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.2 | 6.9 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
1.1 | 4.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.1 | 4.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.1 | 10.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.1 | 8.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.0 | 4.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.0 | 3.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.0 | 5.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.0 | 3.0 | GO:0070840 | dynein complex binding(GO:0070840) |
1.0 | 16.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.0 | 3.9 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.0 | 2.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.9 | 2.8 | GO:0089720 | caspase binding(GO:0089720) |
0.9 | 4.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.9 | 2.7 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.9 | 8.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.8 | 7.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.8 | 5.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 1.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.8 | 2.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.8 | 3.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.8 | 30.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.8 | 8.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.8 | 4.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.8 | 2.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.8 | 2.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.8 | 10.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 1.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.8 | 3.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.8 | 2.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.8 | 3.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.8 | 2.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.8 | 3.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.8 | 1.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.8 | 1.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 5.8 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.7 | 2.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.7 | 8.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.7 | 7.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 16.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.7 | 4.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.7 | 2.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.7 | 4.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.7 | 4.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.7 | 2.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 3.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 1.9 | GO:0004359 | glutaminase activity(GO:0004359) |
0.6 | 6.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.6 | 1.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.6 | 1.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.6 | 1.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.6 | 3.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 0.6 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
0.6 | 5.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 20.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.6 | 9.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.6 | 17.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.6 | 3.4 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 11.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 11.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.6 | 4.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.6 | 3.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.6 | 27.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 3.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 1.6 | GO:0004096 | catalase activity(GO:0004096) |
0.5 | 1.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 5.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 1.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.5 | 6.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 4.7 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.5 | 2.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 3.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.5 | 1.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 3.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.5 | 2.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.5 | 3.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 13.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 1.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 2.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 2.9 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.5 | 6.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 3.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 7.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 2.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.5 | 1.4 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.5 | 2.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 1.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 1.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.5 | 6.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.5 | 2.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.5 | 1.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.5 | 2.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 1.4 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.4 | 8.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 1.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.4 | 1.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 3.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 2.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 1.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.4 | 1.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 0.4 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.4 | 2.8 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 4.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 0.4 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.4 | 0.4 | GO:0030352 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.4 | 3.6 | GO:0034868 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 1.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.4 | 9.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 3.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 4.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 3.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 3.3 | GO:0070990 | snRNP binding(GO:0070990) |
0.4 | 1.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 3.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 4.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 14.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.3 | 4.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 2.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 1.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 8.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 0.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 11.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 2.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 2.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 1.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 9.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 1.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 1.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 1.2 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.3 | 1.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 1.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 0.9 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 9.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 7.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 2.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 2.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 2.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 1.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 1.6 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 2.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 1.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 6.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 1.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 0.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 2.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 1.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 1.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 2.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.3 | 0.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 1.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 0.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 3.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 12.7 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 9.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 0.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 4.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.5 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 1.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 1.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 1.0 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.2 | 1.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 1.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 1.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 4.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 3.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 1.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 2.5 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.2 | 2.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 2.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 4.8 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 0.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 12.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 10.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 1.8 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.7 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 21.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 1.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 4.6 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.2 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 32.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 14.9 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 2.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 5.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 3.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 2.8 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.0 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 2.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 4.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 9.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 2.8 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 4.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 2.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.2 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 12.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 2.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 20.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 1.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 11.7 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.2 | 0.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 4.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 24.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 3.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.6 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 3.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 1.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 108.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 4.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 1.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 2.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 7.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.7 | GO:0042299 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 8.6 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.5 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 31.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 1.1 | GO:0043759 | succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 2.0 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 2.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.7 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 2.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 2.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 1.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 3.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 2.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 1.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 2.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.2 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 16.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 16.4 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 2.0 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 7.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.9 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.3 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 3.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.7 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 2.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 1.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.1 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.1 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.4 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 16.7 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.5 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.5 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.0 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.2 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.0 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.0 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 43.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.2 | 20.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.9 | 18.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.8 | 4.9 | PID MYC PATHWAY | C-MYC pathway |
0.6 | 15.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.6 | 2.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.6 | 9.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 18.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 2.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 27.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.5 | 1.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 10.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 15.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 6.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 12.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 5.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 12.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 3.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 18.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 10.2 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 2.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 6.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 1.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 2.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 4.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 19.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 3.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 14.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 9.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 7.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 3.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 6.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 3.5 | PID ATM PATHWAY | ATM pathway |
0.3 | 4.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 1.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 1.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 2.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 10.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 5.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 4.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 2.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 1.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 2.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 1.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 4.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 4.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 6.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 1.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 2.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 3.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.8 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.3 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 1.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 3.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.3 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 19.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.5 | 24.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.8 | 21.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.7 | 3.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.6 | 1.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.5 | 16.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.2 | 15.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.2 | 1.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
1.2 | 1.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.2 | 19.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.1 | 10.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.1 | 12.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.0 | 8.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.9 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.9 | 2.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 17.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.7 | 2.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.7 | 16.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.6 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.6 | 3.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 3.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.6 | 13.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 6.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.6 | 1.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.6 | 9.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.6 | 1.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.6 | 3.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.5 | 3.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 42.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 4.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 21.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 14.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.5 | 6.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 3.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 8.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 3.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 7.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 5.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 6.7 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 38.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.4 | 17.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 1.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 3.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 2.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 5.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 5.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 7.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 6.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 6.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 1.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 2.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 4.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 8.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 4.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 3.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 6.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.3 | 2.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 5.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 3.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 14.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 0.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 24.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 3.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 1.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 3.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 0.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.3 | 2.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 2.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 3.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.2 | 1.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 2.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 2.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 0.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 1.6 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 1.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 4.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 3.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 1.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 1.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 3.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 4.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 2.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 6.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 2.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 2.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 3.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 1.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.3 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.2 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 7.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 1.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 8.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 1.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.8 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 1.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.9 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 9.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 14.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.7 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.7 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.3 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 0.9 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 3.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 3.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.2 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 2.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.2 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 1.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.0 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.1 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |